The APOE ϵ4 Allele Is Associated with Lower Selenium Levels in the Brain: Implications for Alzheimer's Disease
- Publication Type:
- Journal Article
- ACS Chemical Neuroscience, 2017, 8 (7), pp. 1459 - 1464
- Issue Date:
|The APOE ε4 Allele Is Associated with Lower Selenium Levels in the Brain Implications for Alzheimer’s Disease.pdf||Published Version||697.53 kB|
Copyright Clearance Process
- Recently Added
- In Progress
- Closed Access
This item is closed access and not available.
© 2017 American Chemical Society. The antioxidant activity of selenium, which is mainly conferred by its incorporation into dedicated selenoproteins, has been suggested as a possible neuroprotective approach for mitigating neuronal loss in Alzheimer's disease. However, there is inconsistent information with respect to selenium levels in the Alzheimer's disease brain. We examined the concentration and cellular compartmentalization of selenium in the temporal cortex of Alzheimer's disease and control brain tissue. We found that Alzheimer's disease was associated with decreased selenium concentration in both soluble (i.e., cytosolic) and insoluble (i.e., plaques and tangles) fractions of brain homogenates. The presence of the APOE ϵ4 allele correlated with lower total selenium levels in the temporal cortex and a higher concentration of soluble selenium. Additionally, we found that age significantly contributed to lower selenium concentrations in the peripheral membrane-bound and vesicular fractions. Our findings suggest a relevant interaction between APOE ϵ4 and selenium delivery into brain, and show changes in cellular selenium distribution in the Alzheimer's disease brain.
Please use this identifier to cite or link to this item: